Chrome 2001
.
The Trusted Source InteliHealth Aetna InteliHealth Aetna InteliHealth
Enter Drug Name . Enter Search Term
     
. .
. .
.
Home
Health Commentaries
InteliHealth Dental
Drug Resource Center
Ask the Expert
Interactive Tools

InteliHealth Policies
Site Map

.
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Health News Health News
.
.

Powerful HIV Antibodies Found for Vaccine
July 8, 2010

WASHINGTON (Deutsche Presse-Agentur) -- US scientists have discovered the most effective HIV antibodies to date which can be used to find a vaccine for the virus, Science reported Thursday.

A team of researchers coordinated by the National Institutes of Health (NIH) found the two proteins that can neutralize more than 90 per cent of known global strains of HIV.

The VRC01 and VRC02 antibodies neutralize more strains with greater strength than any other previously known antibody, the study said.

After finding out how the antibodies work and where they attach to the virus, the scientists started developing a potential vaccine. They also said that their work could be used in HIV treatment.

"In addition, the technique the teams used to find the new antibodies represents a novel strategy that could be applied to vaccine design for many other infectious diseases," said Anthony Fauci, director of the NIH's National Institute of Allergy and Infectious Diseases.

An AIDS vaccine that will prevent HIV infection as effectively as vaccines prevent polio and other viral infections is still several years away. Vaccine development is expensive and daunting because HIV is a moving target, mutating readily.

Finding individual antibodies that can neutralize HIV strains is difficult because the virus is constantly changing its surface proteins to evade recognition by the immune system -- resulting in a very large number of HIV variants worldwide.

But the newly found antibodies "attach to a virtually unchanging part of the virus, and this explains why they can neutralize such an extraordinary range of HIV strains," said John Mascola, who led one of the study teams.

The findings were published shortly before a large international AIDS conference that brings together scientists, international bodies and non-governmental advocates in Vienna from July 18.

Copyright 2010 dpa Deutsche Presse-Agentur GmbH

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
General Health
Top News
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Environmental Health
Eyes
Family Health
Fitness
Genetics
Headache
Health Policy
HIV / AIDS
Heart Health
Lung Cancer
Medications
Infectious Diseases
Men's Health
Nutrition News
Mental Health
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
.
.  
This website is certified by Health On the Net Foundation. Click to verify.
.
Chrome 2001
Chrome 2001